Canada Pension Plan Investment Board Immuno Gen, Inc. Transaction History

Canada Pension Plan Investment Board

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$12.46 - $29.95 $7.31 Million - $17.6 Million	586,990 New	586,990 $17.4 Million
Q1 2020 May 13, 2020	SELL	$2.12 - $6.8 $2.6 Million - $8.33 Million	-1,224,900 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.25 - $5.8 $1.18 Million - $3.04 Million	524,900 Added 74.99%	1,224,900 $6.25 Million
Q3 2019 Nov 12, 2019	BUY	$2.22 - $3.39 $1.55 Million - $2.37 Million	700,000 New	700,000 $1.69 Million

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.